HETERO LABS LIMITED

Location

Telangana

Founded

1989-03-10

Risk Signals

265 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about HETERO LABS LIMITED

Live alerts from global media, monitored by Business Radar

Hetero Labs Hiring Event| Calling all Freshers!

2024-11-21 (sakshi.com)

Hetero Labs Hiring Event| Calling all Freshers!

Hetero Labs is hosting a recruitment drive for various positions across their organization. This is a great opportunity to launch your career in the pharmaceutical industry.

Read more
Premiere: 30 Days of Lust: New SWR series about love, sex and open relationships

2024-10-25 (stuttgarter-zeitung.de)

Premiere: 30 Days of Lust: New SWR series about love, sex and open relationships

What if you're about to turn 30 and have only had sex with your long-term partner your whole life? Final panic! The new series “30 Days of Lust” produced in Stuttgart accompanies a Stuttgart couple on their escapades.

Read more
Ivacaftor API Market to Set an Explosive Growth in Near Future | Cipla, Mylan N.V., Hetero Drugs Limited

2024-10-10 (openpr.com)

Ivacaftor API Market to Set an Explosive Growth in Near Future | Cipla, Mylan N.V., Hetero Drugs Limited

Press release - Infinity Business Insights - Ivacaftor API Market to Set an Explosive Growth in Near Future | Cipla, Mylan N.V., Hetero Drugs Limited - published on openPR.com

Read more
Walk in Drive for Quality Control Department at Hetero Plasma Science

2024-09-27 (pharmatutor.org)

Walk in Drive for Quality Control Department at Hetero Plasma Science

Biological therapeutic protein testing and release QMS practices, audit management in QC Biopharma setup validations, software qualifications, OOT, OOS, Change controls, incidents, deviations, investigations and CAPA

Read more
Generically Speaking: A Hatch-Waxman Litigation Bulletin Second Quarter - Generic Launches

2024-09-10 (jdsupra.com)

Generically Speaking: A Hatch-Waxman Litigation Bulletin Second Quarter - Generic Launches

This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated...

Read more
Wild leopard caught in Hetero Labs released in Amrabad Tiger Reserve

2023-09-24 (deccanchronicle.com)

Wild leopard caught in Hetero Labs released in Amrabad Tiger Reserve

Captured leopard released into Mannanur forests. (Photo by arrangement)

Read more
Hetero unveils new logo and corporate brand identity

2022-05-12 (expresspharma.in)

Hetero unveils new logo and corporate brand identity

The new logo is effective immediately and will be implemented across the group’s companies, solutions, assets, services and products in due course

Read more
Q&A: Camber’s Ostaficiuk discusses generic firm’s growing portfolio

2021-08-23 (drugstorenews.com)

Q&A: Camber’s Ostaficiuk discusses generic firm’s growing portfolio

DSN talks to Camber Pharmaceuticals president Kon Ostaficiuk about the company's pandemic efforts and the recent additions to its pharmaceutical and store-brand OTC offerings.

Read more
Hetero to develop injection form of COVID-19 drug Favipiravir

2020-10-08 (businesstoday.in)

Hetero to develop injection form of COVID-19 drug Favipiravir

Favipiravir which was originally designed to cure influenza is now used in the treatment of coronavirus patients.

Read more
Hetero launches Favivir to treat mild to moderate Covid-19

2020-07-29 (expresspharma.in)

Hetero launches Favivir to treat mild to moderate Covid-19

Favivir, priced at Rs 59 per tablet, will be available at all retail medical outlets and hospital pharmacies across the country but will be sold only on prescription

Read more
Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment

2020-06-21 (expresspharma.in)

Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment

COVIFOR will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner

Read more
Coronavirus drug update: Cipla, Hetero to launch Remdesivir at Rs 3,000-6,000

2020-06-21 (businesstoday.in)

Coronavirus drug update: Cipla, Hetero to launch Remdesivir at Rs 3,000-6,000

Cipla plans to launch the drug in a couple of days, while Hetero's drug is expected to hit the market in a week

Read more

Never miss a headline about HETERO LABS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages